The impact of the COVID-19 pandemic on vaccine coverage in Kilifi, Kenya: A retrospective cohort study

<p>The COVID-19 pandemic caused unprecedented disruption in health service delivery, globally. This study sought to provide evidence on the impact of the pandemic on vaccine coverage in Kilifi County, Kenya. We conducted a vaccine coverage survey between April and June 2021 within the Kilifi H...

Full description

Bibliographic Details
Main Authors: Lucinde, RK, Karia, B, Ouma, N, Amadi, D, Nyundo, C, Mataza, C, Nyaguara, A, Scott, JAG, Gallagher, KE, Kagucia, E
Format: Journal article
Language:English
Published: Elsevier 2023
_version_ 1797110552727650304
author Lucinde, RK
Karia, B
Ouma, N
Amadi, D
Nyundo, C
Mataza, C
Nyaguara, A
Scott, JAG
Gallagher, KE
Kagucia, E
author_facet Lucinde, RK
Karia, B
Ouma, N
Amadi, D
Nyundo, C
Mataza, C
Nyaguara, A
Scott, JAG
Gallagher, KE
Kagucia, E
author_sort Lucinde, RK
collection OXFORD
description <p>The COVID-19 pandemic caused unprecedented disruption in health service delivery, globally. This study sought to provide evidence on the impact of the pandemic on vaccine coverage in Kilifi County, Kenya. We conducted a vaccine coverage survey between April and June 2021 within the Kilifi Health and Demographic Surveillance System (KHDSS). Simple random sampling was used to identify 1500 children aged 6 weeks–59 months. Participants were grouped into three retrospective cohorts based on when they became age-eligible for vaccination: before the pandemic, during the first year, or during the second year of the pandemic. Survival analysis with Cox regression was used to evaluate the association between the time-period at which participants became age-eligible for vaccination and the rate of vaccination within a month of age-eligibility for the third dose of pentavalent vaccine (Pentavalent-3) and within three months of age-eligibility for the first dose of Measles vaccine (MCV-1). A total of 1,341 participants were included in the survey. Compared to the pre-COVID-19 baseline period, the rate of vaccination within a month of age-eligibility for Pentavalent-3 was not significantly different in the first year of the pandemic (adjusted hazard ratio [aHR] 1.03, 95 % confidence interval [CI] 0.90–1.18) and was significantly higher during the second year of the pandemic (aHR 1.33, 95 % CI 1.07–1.65). The rate of vaccination with MCV-1 within three months of age-eligibility was not significantly different among those age-eligible for vaccination during the first year of the pandemic (aHR 1.04, 95 % CI 0.88–1.21) and was 35 % higher during the second year of the pandemic (95 % CI 1.11–1.64), compared to those age-eligible pre-COVID-19. After adjusting for known determinants of vaccination, the COVID-19 pandemic did not adversely affect the rate of vaccination within the KHDSS.</p>
first_indexed 2024-03-07T07:56:24Z
format Journal article
id oxford-uuid:a3fe45da-aa16-4141-87d5-65272601b1d1
institution University of Oxford
language English
last_indexed 2024-03-07T07:56:24Z
publishDate 2023
publisher Elsevier
record_format dspace
spelling oxford-uuid:a3fe45da-aa16-4141-87d5-65272601b1d12023-08-16T14:35:25ZThe impact of the COVID-19 pandemic on vaccine coverage in Kilifi, Kenya: A retrospective cohort studyJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:a3fe45da-aa16-4141-87d5-65272601b1d1EnglishSymplectic ElementsElsevier 2023Lucinde, RKKaria, BOuma, NAmadi, DNyundo, CMataza, CNyaguara, AScott, JAGGallagher, KEKagucia, E<p>The COVID-19 pandemic caused unprecedented disruption in health service delivery, globally. This study sought to provide evidence on the impact of the pandemic on vaccine coverage in Kilifi County, Kenya. We conducted a vaccine coverage survey between April and June 2021 within the Kilifi Health and Demographic Surveillance System (KHDSS). Simple random sampling was used to identify 1500 children aged 6 weeks–59 months. Participants were grouped into three retrospective cohorts based on when they became age-eligible for vaccination: before the pandemic, during the first year, or during the second year of the pandemic. Survival analysis with Cox regression was used to evaluate the association between the time-period at which participants became age-eligible for vaccination and the rate of vaccination within a month of age-eligibility for the third dose of pentavalent vaccine (Pentavalent-3) and within three months of age-eligibility for the first dose of Measles vaccine (MCV-1). A total of 1,341 participants were included in the survey. Compared to the pre-COVID-19 baseline period, the rate of vaccination within a month of age-eligibility for Pentavalent-3 was not significantly different in the first year of the pandemic (adjusted hazard ratio [aHR] 1.03, 95 % confidence interval [CI] 0.90–1.18) and was significantly higher during the second year of the pandemic (aHR 1.33, 95 % CI 1.07–1.65). The rate of vaccination with MCV-1 within three months of age-eligibility was not significantly different among those age-eligible for vaccination during the first year of the pandemic (aHR 1.04, 95 % CI 0.88–1.21) and was 35 % higher during the second year of the pandemic (95 % CI 1.11–1.64), compared to those age-eligible pre-COVID-19. After adjusting for known determinants of vaccination, the COVID-19 pandemic did not adversely affect the rate of vaccination within the KHDSS.</p>
spellingShingle Lucinde, RK
Karia, B
Ouma, N
Amadi, D
Nyundo, C
Mataza, C
Nyaguara, A
Scott, JAG
Gallagher, KE
Kagucia, E
The impact of the COVID-19 pandemic on vaccine coverage in Kilifi, Kenya: A retrospective cohort study
title The impact of the COVID-19 pandemic on vaccine coverage in Kilifi, Kenya: A retrospective cohort study
title_full The impact of the COVID-19 pandemic on vaccine coverage in Kilifi, Kenya: A retrospective cohort study
title_fullStr The impact of the COVID-19 pandemic on vaccine coverage in Kilifi, Kenya: A retrospective cohort study
title_full_unstemmed The impact of the COVID-19 pandemic on vaccine coverage in Kilifi, Kenya: A retrospective cohort study
title_short The impact of the COVID-19 pandemic on vaccine coverage in Kilifi, Kenya: A retrospective cohort study
title_sort impact of the covid 19 pandemic on vaccine coverage in kilifi kenya a retrospective cohort study
work_keys_str_mv AT lucinderk theimpactofthecovid19pandemiconvaccinecoverageinkilifikenyaaretrospectivecohortstudy
AT kariab theimpactofthecovid19pandemiconvaccinecoverageinkilifikenyaaretrospectivecohortstudy
AT ouman theimpactofthecovid19pandemiconvaccinecoverageinkilifikenyaaretrospectivecohortstudy
AT amadid theimpactofthecovid19pandemiconvaccinecoverageinkilifikenyaaretrospectivecohortstudy
AT nyundoc theimpactofthecovid19pandemiconvaccinecoverageinkilifikenyaaretrospectivecohortstudy
AT matazac theimpactofthecovid19pandemiconvaccinecoverageinkilifikenyaaretrospectivecohortstudy
AT nyaguaraa theimpactofthecovid19pandemiconvaccinecoverageinkilifikenyaaretrospectivecohortstudy
AT scottjag theimpactofthecovid19pandemiconvaccinecoverageinkilifikenyaaretrospectivecohortstudy
AT gallagherke theimpactofthecovid19pandemiconvaccinecoverageinkilifikenyaaretrospectivecohortstudy
AT kaguciae theimpactofthecovid19pandemiconvaccinecoverageinkilifikenyaaretrospectivecohortstudy
AT lucinderk impactofthecovid19pandemiconvaccinecoverageinkilifikenyaaretrospectivecohortstudy
AT kariab impactofthecovid19pandemiconvaccinecoverageinkilifikenyaaretrospectivecohortstudy
AT ouman impactofthecovid19pandemiconvaccinecoverageinkilifikenyaaretrospectivecohortstudy
AT amadid impactofthecovid19pandemiconvaccinecoverageinkilifikenyaaretrospectivecohortstudy
AT nyundoc impactofthecovid19pandemiconvaccinecoverageinkilifikenyaaretrospectivecohortstudy
AT matazac impactofthecovid19pandemiconvaccinecoverageinkilifikenyaaretrospectivecohortstudy
AT nyaguaraa impactofthecovid19pandemiconvaccinecoverageinkilifikenyaaretrospectivecohortstudy
AT scottjag impactofthecovid19pandemiconvaccinecoverageinkilifikenyaaretrospectivecohortstudy
AT gallagherke impactofthecovid19pandemiconvaccinecoverageinkilifikenyaaretrospectivecohortstudy
AT kaguciae impactofthecovid19pandemiconvaccinecoverageinkilifikenyaaretrospectivecohortstudy